These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20351678)

  • 21. [Acquired von Willebrand syndrome in two children with congenital heart defects and abnormal haemodynamics].
    Voges I; Burstein C; Budde U; Lenschow U
    Hamostaseologie; 2006 Nov; 26(4):345-8. PubMed ID: 17146548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

  • 23. Acquired von Willebrand's disease following bone marrow transplantation.
    Lazarchick J; Green C
    Ann Clin Lab Sci; 1994; 24(3):211-5. PubMed ID: 8048792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of acquired von Willebrand's syndrome associated with IgG myeloma (author's transl)].
    Matsuda S; Aoki I; Kikuchi M; Muraki H; Toyama K
    Rinsho Ketsueki; 1977 Aug; 18(8):1007-12. PubMed ID: 303298
    [No Abstract]   [Full Text] [Related]  

  • 25. Unusual bleeds, unusual clots.
    Moll S
    Hamostaseologie; 2007 Aug; 27(3):191-9. PubMed ID: 17694227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome.
    Federici AB
    Hum Immunol; 2005 Apr; 66(4):422-30. PubMed ID: 15866707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies.
    Sucker C; Michiels JJ; Zotz RB
    Acta Haematol; 2009; 121(2-3):177-82. PubMed ID: 19506364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Patients with von Willebrand Disease with ISTH/BAT and PBQ Scores.
    Belen Apak FB; Ümit EG; Zengin Y; Sezgin Evim M; Ünal E; Özbaş HM; Acıpayam C
    Turk J Haematol; 2020 Feb; 37(1):57-58. PubMed ID: 31718118
    [No Abstract]   [Full Text] [Related]  

  • 29. [Role of the thrombocytes in the pathogenesis of von Willebrand's disease].
    Novosadov VM; Koniukhov SG; Sadkov SA; Tarasova LN; Kriazhev LN
    Sov Med; 1982; (1):39-42. PubMed ID: 6977872
    [No Abstract]   [Full Text] [Related]  

  • 30. Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus.
    Viallard JF; Pellegrin JL; Vergnes C; Borel-Derlon A; Clofent-Sanchez G; Nurden AT; Leng B; Nurden P
    Br J Haematol; 1999 May; 105(2):532-7. PubMed ID: 10233433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab failure in a patient with monoclonal gammopathy of undetermined significance (MGUS)-associated acquired von Willebrand syndrome.
    Grimaldi D; Bartolucci P; Gouault-Heilmann M; Martin-Toutain I; Khellaf M; Godeau B
    Thromb Haemost; 2008 Apr; 99(4):782-3. PubMed ID: 18392339
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndrome.
    Macik BG; Gabriel DA; White GC; High K; Roberts H
    Arch Pathol Lab Med; 1988 Feb; 112(2):143-6. PubMed ID: 2447856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Von-Willebrand-Jürgens syndrome].
    Winckelmann G
    Med Klin; 1973 Jan; 68(2):37-42. PubMed ID: 4567798
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnosis and treatment of von Willebrand disease.
    Cox Gill J
    Hematol Oncol Clin North Am; 2004 Dec; 18(6):1277-99, viii. PubMed ID: 15511616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired von Willebrand's syndrome resulting from untreated hypothyroidism in two prepubertal girls.
    Galli-Tsinopoulou A; Stylianou C; Papaioannou G; Nousia-Arvanitakis S
    Haemophilia; 2006 Nov; 12(6):687-9. PubMed ID: 17083524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acquired von Willebrand syndrome with autoimmune hemolytic anemia].
    Ishimaru F; Hayashi H; Fujita T; Tsurumi N; Tsuda T; Kimura I
    Rinsho Ketsueki; 1990 Sep; 31(9):1493-8. PubMed ID: 2246822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Von Willebrand disease: a common and unrecognized bleeding disorder].
    Boehlen F; Robert-Ebadi H; de Moerloose P
    Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome.
    Luboshitz J; Lubetsky A; Schliamser L; Kotler A; Tamarin I; Inbal A
    Thromb Haemost; 2001 May; 85(5):806-9. PubMed ID: 11372672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thrombasthenia, thrombopathy, von Willebrand's disease (hemorrhagic diathesis caused by the congenital disorder of primary hemostasis)].
    Rák K
    Orv Hetil; 1969 Mar; 110(12):637-45. PubMed ID: 4889625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.